TransMedics Group (TMDX)

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Aksjekursen TransMedics Group, Inc. Common Stock (TMDX) after-hours i dag er 147,06 $, som gjenspeiler en bevegelse på +1,23 % after-hours siden markedet sist stengte. Selskapets markedsverdi er $ 5,03 mrd., med et daglig handelsvolum på $ 1,09 mill. aksjer. For investorer som følger kursutviklingen, har TransMedics Group, Inc. Common Stock-aksjen ligget mellom 137,94 $  og 147,66 $ i dag. Den forrige lukkekursen var 145,27 $.

Er du klar til å komme i gang? Følg trinnene nedenfor, eller les vår guide om hvordan kjøpe TransMedics Group aksje på Kraken fra $10.